Deutsche Bank analyst Emmanuel Papadakis raised the price target on Zealand Pharma A/S (ZEAL:DC) (NASDAQ: ZEAL) to DKK300.00 (from DKK275.00) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE